SCHEMBL764155

SCHEMBL764155

CPNCC(C)Cc1ccccc1OCC(C)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 11/20 0.46
ADRB1 P08588 11/20 0.46
LMNA P02545 3/20 0.44
ADRB3 P13945 2/20 0.44
HTR1A P08908 1/20 0.44
ADRA2C P18825 1/20 0.44
SLC6A2 P23975 1/20 0.44
BDKRB2 P30411 1/20 0.44
SLC6A4 P31645 1/20 0.44
ADRA1A P35348 1/20 0.44
HTR2B P41595 1/20 0.44
KCNH2 Q12809 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
KDM4E B2RXH2 1/20 0.43
PMP22 Q01453 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ALDH1A1 P00352 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14260229 0.84 ADRB2 (0.39) ADRB2ADRB1LMNAADRB3HTR1A
SCHEMBL10150183 0.81 ALDH1A1 (0.36) ADRB2ADRB1LMNAADRB3HTR1A
SCHEMBL13392151 0.80 LMNA (0.47) ADRB2ADRB1LMNAADRB3HTR1A
SCHEMBL13410928 0.80 CYP1A2 (0.49) ADRB2ADRB1LMNAADRB3HTR1A
SCHEMBL745791 0.80 CYP1A2 (0.49) ADRB2ADRB1LMNAADRB3HTR1A
SCHEMBL14260234 0.80 LMNA (0.34) ADRB2ADRB1LMNAADRB3CYP2D6
SCHEMBL750165 0.79 ALOX15 (0.48) ADRB2ADRB1LMNAADRB3HTR1A
SCHEMBL14046821 0.78 ADRB2 (0.52) ADRB2ADRB1
SCHEMBL3303039 0.75 ADRB2 (0.51) ADRB2ADRB1HTR1A
SCHEMBL12310073 0.73 LMNA (0.53) ADRB2ADRB1LMNAADRB3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2431380-A2 Macrocyclic antagonist of the motilin receptor for treatment of gastrointestinal dysmotility disorders Tranzyme Pharma, Inc. (US) 2012-03-21 EP disclosed
WO-2008033328-A2 MACROCYCLIC ANTAGONISTS OF THE MOTILIN RECEPTOR FOR TREATMENT OF GASTROINTESTINAL DYSMOTILITY DISORDERS TRANZYME PHARMA, INC. (US) 2008-03-20 WO disclosed